Content tagged with: Occupational Hygiene
Found 56 matches.
Refine Search Results
Greener Nano 12: Nanoinformatics Tools and Resources WorkshopMay. 2012- July 30, 2012Courtyard Marriott Portland City CenterPortland, Oregon The quantity of information on nanomaterial properties and behavior continues to grow exponentially. Without a concerted effort to organize and mine disparate information coming out of current research efforts, the value and effective use of this information will be limited at best. At worst, erroneous conclusions ... |
NanoBusiness Provides Insight on National Research Council ReportFeb. 2012- The National Research Council (NRC) of the National Academies has been working for several years on the development of a Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials. On January 25th they released a draft of this strategy, which is available from the National Academies website. This work was commissioned by the Environmental Protection Agency. A ... |
Responsible Development of Nanotechnology: Maximizing Results while Minimizing RiskOct. 2011- Nanotechnology holds the promise of new materials and devices that can be designed and engineered to solve critical questions in almost every sector of our economy – from treating cancer, to cleaning contaminated water, accelerating advanced manufacturing, meeting energy needs, and fixing our roadways and bridges. That’s why, for the last 10 years, the United States has engaged in an ... |
SWeNT is currently the Only U.S. Manufacturer Permitted to Commercially Distribute Both Multi-Wall and Single-Wall Carbon NanotubesSep. 2011- NORMAN, OK – Sept. 21, 2011 -- SouthWest NanoTechnologies, Inc. (SWeNT), the world leader in high quality carbon nanotubes (CNT), recently received an Environmental Protection Agency (EPA) consent order which will permit the company to manufacture and distribute Multi-Wall Carbon Nanotubes (MWCNT) for commercial applications. SWeNT’s Multi-Wall products are sold under the SWeNT ... |
Informing Selection of Nanomaterial Concentrations for ToxCast In Vitro Testing based on Occupational Exposure PotentialAug. 2011- "Informing Selection of Nanomaterial Concentrations for ToxCast In Vitro Testing based on Occupational Exposure Potential" is now available through the InterNano Nanomanufacturing Library. The full article is available here. Abstract Background: Little justification is generally provided for selection of in vitro assay testing concentrations for engineered nanomaterials (ENMs). ... |
ISO Publishes New Nanotechnology Standard: Nanomaterial Risk EvaluationMay. 2011- ISO/TR 13121:2011 describes a process for identifying, evaluating, addressing, making decisions about, and communicating the potential risks of developing and using manufactured nanomaterials, in order to protect the health and safety of the public, consumers, workers and the environment.ISO/TR 13121:2011 offers guidance on the information needed to make sound risk evaluations and risk management ... |
National Nanotechnology Initiative Issues New EHS-Strategy DocumentDec. 2010- On December 6, 2010, the Nanoscale Science, Engineering, and Technology Subcommittee of the National Science and Technology Council's Committee on Technology released the draft "National Nanotechnology Initiative 2011 Environmental, Health, and Safety Strategy" (2011 NNI EHS Research Strategy). The document is intended to replace the National Nanotechnology Initiative's ... |
Hazardous Substances Data Bank Adds First Set of Nanomaterials RecordsNov. 2009- In October, the National Library of Medicine's Hazardous Substances Data Bank (HSBD)—a comprehensive, peer-reviewed database of toxicology information for over 5,000 chemicals—added seven nanomaterials records, the first set of such records in the datafile. |
GoodNanoGuide Shares Best PracticesJun. 2009- Press Release: The Rice University-based International Council on Nanotechnology (ICON) today introduced the GoodNanoGuide, an online, community-driven wiki for information about the safe handling of nanomaterials. |
Nanomaterial Safety: Two Steps ForwardApr. 2009- National Nanomanufacturing Network: The Organization for Economic Cooperation and Development (OECD) and the National Institute for Occupational Safety and Health (NIOSH) are moving the issue of safe handling of manufactured nanomaterials forward, step by step. |
Best Practices for Working With NanoparticlesJan. 2009- National Nanomanufacturing Network: Drs. Michael Ellenbecker and Candace Tsai of the University of Massachusetts Lowell have authored a working document, Interim Best Practices for Working with Nanoparticles, for use at the NSF Center for High-rate Nanomanufacturing (CHN). This publicly available document will be discussed at the upcoming 2nd Annual Massachusetts Nanotechnology Workshop in ... |
Considerations on Occupational Medical Surveillance in Employees Handling NanoparticlesNov. 2007- The authors discuss the appropriateness of establishing occupational medical surveillance programs for workers handling nanomaterials. Because there is no information yet available on health outcomes that may be associated with exposure to nanoparticles, the authors suggest general medical screening, baseline examinations, and establishment of exposure registries to document who is currently ... |
Repository
A Review of Published Quantitative Experimental Studies on Factors Affecting Laboratory Fume Hood PerformanceThis study attempted to identify the important factors that affect the performance of a laboratory fume hood and the relationship between the factors and hood performance under various conditions by analyzing and generalizing the results from other studies that quantitatively investigated fume hood performance. A literature search identified 43 studies that were published from 1966 to 2006. For ... |
Airborne nanoparticle exposures associated with the manual handling of nanoalumina and nanosilver in fume hoodsManual handling of nanoparticles is a fundamental task of most nanomaterial research; such handling may expose workers to ultrafine or nanoparticles. Recent studies confirm that exposures to ultrafine or nanoparticles produce adverse inflammatory responses in rodent lungs and such particles may translocate to other areas of the body, including the brain. An important method for protecting workers ... |
Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered NanomaterialsNIOSH has developed this document to provide an overview of what is known about the potential hazards of engineered nanoparticles and measures that can be taken to minimize workplace exposures. |
Considerations in the Application of Nanoinformatics to Occupational Safety and HealthThis presentation will describe the information needs in occupational safety and health and issues in applying informatics techniques to hazard identification, exposure assessment, risk assessment, and risk management. |
Considerations on Occupational Medical Surveillance in Employees Handling NanoparticlesThe use of engineered nanoparticles not only offers new technical perspectives but also raises questions regarding possible health aspects for producers and users. Nanoparticles may, just by virtue of their size, exert biological effects unrelated to the chemicals they are composed of. These considerations, and results from experimental animal studies suggesting that engineered nanomaterials may ... |
Exposure to nanoscale particles and fibers during machining of hybrid advanced composites containing carbon nanotubesThis study investigated airborne exposures to nanoscale particles and fibers generated during dry and wet abrasive machining of two three-phase advanced composite systems containing carbon nanotubes (CNTs), micron-diameter continuous fibers (carbon or alumina), and thermoset polymer matrices. Exposures were evaluated with a suite of complementary instruments, including real-time particle number ... |
Interim Best Practices for Working with NanoparticlesThis document was written to provide interim best safety and health practices to students, staff and faculty of the Center for High-rate Nanomanufacturing (CHN) who work with nanoparticles. This contain "interim" best practices because the field of nanoparticle health and safety is rapidly evolving at this time; there is much that is not known about the toxicity of nanoparticle and the hazards of ... |
Manufacturing at the NanoscaleReport of the National Nanotechnology Initiative Workshop 2002-2004 |
Nanoinformatics 2011 Supports Updated NNI EHS Research StrategyThe responsible development of nanotechnology has an impact across essentially all economic sectors, including advanced manufacturing. As core research areas of the recently released 2011 National Nanotechnology Initiative (NNI) Environmental Health and Safety (EHS) Research Strategy include a nanomaterials measurement infrastructure, as well as informatics and modeling, it has become evident ... |
Nanomanufacturing 2010: A Review of Events and MilestonesThe past year has been very exciting as we have witnessed the establishment of several nanomanufacturing methods within industry roadmaps, along with numerous companies moving closer to commercial viability of nano-enabled products. This comes in a timely fashion as we celebrate the 10th anniversary of the National Nanotechnology Initiative (NNI), which has catapulted the U.S. to a global ... |
Nanoparticle Exposure Assessment and ControlOur mission is to ensure all students and researchers are working safely with nanoparticles at the Center for High-rate Nanomanufacturing (CHN). We employed unique equipment to evaluate airborne nanoparticle exposures in CHN laboratories and Industry facilities. Furthermore, we develop best practices and engineering controls for nanoparticles applications. |
Nanoparticle Information LibraryThe Nanoparticle Information Library (NIL) was established in 2004 by the National Institute for Occupational Safety and Health (NIOSH) and its national and international partners as part of the NIOSH Nanotechnology Research Program. The NIL is a searchable database of nanoparticle properties and associated health and safety information designed to help occupational health professionals, ... |
National Nanotechnology Initiative: Environmental, Health, and Safety Research StrategyNanotechnology safety benefits everyone, from lab researchers and factory workers to the consumers of products enabled by this emerging technology. Accordingly, the Federal Government has developed the 2011 NNI Environmental, Health, and Safety (EHS) Research Strategy, a comprehensive approach to ensuring the safe, effective, and responsible development and use of nanotechnology. The NNI 2011 ... |
Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative AssessmentBackground: Quantum dots (QDs) are autofluorescent semiconductor nanocrystals that can be used for in vivo biomedical imaging. However, we know little about their in vivo disposition and health consequences. Objectives: We assessed the tissue disposition and pharmacokinetics of QD705 in mice. Methods: We determined quantitatively the blood and tissue kinetics of QD705 in mice after single ... |
Protecting the Health and Safety of Nanomaterial Workers: A Progress ReportThe number of workers involved with the production, use, distribution, and disposal of nanomaterials and nanomaterial-containing products is increasing as are the number of reports of adverse biological effects of engineered nanoparticles in test systems. However, there are still many unanswered questions about their hazard, worker exposure, resulting risk, and means to manage the risk. The ... |
Strategy for Nanotechnology-Related EHS ResearchThis report describes the NNI strategy for prioritizing research on the environmental health and safety aspects of nanomaterials that have been identified in previous NNI reports. |
Organizations
Abraxis BioScienceAbraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as ABRAXANE, and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. |
Aphios Corp.Aphios is developing enabling technology platforms and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders. |
Berkley Advanced Biomaterials, Inc.Berkeley Advanced Biomaterials Inc. (BAB) specializes in developing and manufacturing hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products. |
Bio-Rad LaboratoriesThe Group's principal activities are to manufacture and develop chemicals used in biochemical, pharmaceutical and other life science research applications. |
BIOMET 3iBIOMET 3i offers one of the most comprehensive lines of dental implants and dental implant abutments, augmented by a growing line of site preparation and regenerative products. BIOMET 3i pioneered the development of biologically driven dental implants, winning worldwide acclaim for the microtextured surface and superior clinical success rates of the OSSEOTITE® Dental Implants. |
Birck Nanotechnology CenterPurdue University |
Calando PharmaceuticalsCalando is a clinical stage nanobiotechnology company at the forefront of RNAi therapeutics. |
Celgene CorporationCelgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer ... |
Eksigent Technologies, LLCEksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low–flow fluid delivery solutions |
Electric Power Research InstituteThe Electric Power Research Institute, Inc. (EPRI) conducts research and development relating to the generation, delivery and use of electricity for the benefit of the public. |
ENVIRON International Corporation, Inc.An international environmental and health sciences consultancy, ENVIRON works with clients to assess and manage the potential environmental, energy, and health issues associated with their activities and products, including nanotechnology, throughout the business life cycles. ENVIRON's efforts in nanotechnology are focused on working with companies, law firms and organizations to develop a ... |

Excellin Life Sciences, Inc.Excellin is a privately-held biotechnology company developing an award-winning consumable-driven technology for cell performance optimization in the biopharmaceutical industry. |
ImaRx Therapeutics, Inc.ImaRx Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for vascular disorders. |
JMarJMAR, LLC is a leading innovator of laser based product solutions; specializing in microbiological detection of organisms in water. |
Mechartes Researchers Pvt. Ltd.CFD Simulations |
Micro Chips Inc.MicroCHIPS is pioneering intelligent implanted devices designed to improve the health of millions of people with chronic conditions that require careful monitoring and precise therapy. Based on proprietary microreservoir technology first developed at the Massachusetts Institute of Technology, MicroCHIPS' platform incorporates long-term implant technologies and wireless communications, as ... |
National Nanotechnology Coordination OfficeThe National Nanotechnology Coordination Office (NNCO) provides technical and administrative support to the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee, which mananges the National Nanotechnology Initiative--the program established in fiscal year 2001 to coordinate Federal nanotechnology research and development. The NNI provides a vision of the long-term ... |
Proctor & GambleThe Procter & Gamble Company engages in the manufacture and sale of consumer goods worldwide. |
SAFENANOInstitute of Occupational Medicine |
TransGenex Nanobiotech, Inc.TGN’s business strategy involves both short- and long-term objectives that will generate revenue in the present and facilitate future R & D. TGN continues to generate revenue from the sales of custom nanoparticles and Nanogene™ reagents and Federal and State grant-funding mechanisms for small businesses to support R & D. TGN plans to develop and market diagnostic reagents/kits for the ... |
Individuals
John DiLoretoNanoReg |

Slava UmanskyInstitute of Health and Safey |

Alex G. FassbenderLockheed Martin Corporation |

Donna HeidelBureau Veritas |

